Jazz Pharmaceuticals plc
JAZZPharmaceutical Preparations · SIC 2834 · CIK 0001232524
Revenue FY2025
$4.27B
Net Income
$(0.36B)
EPS (Basic)
$-5.84
Net Margin
-8.3%
ROE
-8.2%
Total Equity
$4.32B
Shares Out
65M
Jazz Pharmaceuticals plc — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
$394.8M
1.3%
(2.2%)
Tweedy Browne
Tweedy Browne
$14.5M
0.2%
(0.1%)
Renaissance Technologies
Renaissance Technologies
$135.4M
0.1%
(31.4%)
Holocene Advisors
Holocene Advisors
$38.8M
0.1%
(78.1%)
Capital World Investors
Capital World Investors
$650.0M
0.1%
+0.9%
Polen Capital Management
Polen
$0.4M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…